155 related articles for article (PubMed ID: 27013655)
21. Accuracy of volatile urine biomarkers for the detection and characterization of lung cancer.
Mazzone PJ; Wang XF; Lim S; Choi H; Jett J; Vachani A; Zhang Q; Beukemann M; Seeley M; Martino R; Rhodes P
BMC Cancer; 2015 Dec; 15():1001. PubMed ID: 26698840
[TBL] [Abstract][Full Text] [Related]
22. Risk of Lung Cancer Associated with COPD Phenotype Based on Quantitative Image Analysis.
Schwartz AG; Lusk CM; Wenzlaff AS; Watza D; Pandolfi S; Mantha L; Cote ML; Soubani AO; Walworth G; Wozniak A; Neslund-Dudas C; Ardisana AA; Flynn MJ; Song T; Spizarny DL; Kvale PA; Chapman RA; Gadgeel SM
Cancer Epidemiol Biomarkers Prev; 2016 Sep; 25(9):1341-7. PubMed ID: 27383774
[TBL] [Abstract][Full Text] [Related]
23. Small non-coding RNA biomarkers in sputum for lung cancer diagnosis.
Su Y; Guarnera MA; Fang H; Jiang F
Mol Cancer; 2016 May; 15(1):36. PubMed ID: 27176474
[TBL] [Abstract][Full Text] [Related]
24. Autoantibodies against tumor-associated antigens in the early detection of lung cancer.
Dai L; Tsay JC; Li J; Yie TA; Munger JS; Pass H; Rom WN; Zhang Y; Tan EM; Zhang JY
Lung Cancer; 2016 Sep; 99():172-9. PubMed ID: 27565936
[TBL] [Abstract][Full Text] [Related]
25. Assessment of urinary beta-core fragment of human chorionic gonadotropin as a new tumor marker of lung cancer.
Yoshimura M; Nishimura R; Murotani A; Miyamoto Y; Nakagawa T; Hasegawa K; Koizumi T; Shii K; Baba S; Tsubota N
Cancer; 1994 Jun; 73(11):2745-52. PubMed ID: 7514953
[TBL] [Abstract][Full Text] [Related]
26. Six-Month Urinary CCL2 and CXCL10 Levels Predict Long-term Renal Allograft Outcome.
Hirt-Minkowski P; Rush DN; Gao A; Hopfer H; Wiebe C; Nickerson PW; Schaub S; Ho J
Transplantation; 2016 Sep; 100(9):1988-96. PubMed ID: 27548845
[TBL] [Abstract][Full Text] [Related]
27. Sputum microRNA biomarkers for identifying lung cancer in indeterminate solitary pulmonary nodules.
Xing L; Su J; Guarnera MA; Zhang H; Cai L; Zhou R; Stass SA; Jiang F
Clin Cancer Res; 2015 Jan; 21(2):484-9. PubMed ID: 25593345
[TBL] [Abstract][Full Text] [Related]
28. Urinary C-X-C Motif Chemokine 10 Independently Improves the Noninvasive Diagnosis of Antibody-Mediated Kidney Allograft Rejection.
Rabant M; Amrouche L; Lebreton X; Aulagnon F; Benon A; Sauvaget V; Bonifay R; Morin L; Scemla A; Delville M; Martinez F; Timsit MO; Duong Van Huyen JP; Legendre C; Terzi F; Anglicheau D
J Am Soc Nephrol; 2015 Nov; 26(11):2840-51. PubMed ID: 25948873
[TBL] [Abstract][Full Text] [Related]
29. Urinary cotinine and lung cancer risk in a female cohort.
de Waard F; Kemmeren JM; van Ginkel LA; Stolker AA
Br J Cancer; 1995 Sep; 72(3):784-7. PubMed ID: 7669595
[TBL] [Abstract][Full Text] [Related]
30. Metal dyshomeostasis based biomarkers of lung cancer using human biofluids.
Callejón-Leblic B; Gómez-Ariza JL; Pereira-Vega A; García-Barrera T
Metallomics; 2018 Oct; 10(10):1444-1451. PubMed ID: 30168824
[TBL] [Abstract][Full Text] [Related]
31. GM2-activator protein: a new biomarker for lung cancer.
Potprommanee L; Ma HT; Shank L; Juan YH; Liao WY; Chen ST; Yu CJ
J Thorac Oncol; 2015 Jan; 10(1):102-9. PubMed ID: 25490003
[TBL] [Abstract][Full Text] [Related]
32. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
[TBL] [Abstract][Full Text] [Related]
33. Levels of tobacco-specific metabolites among non-smoking lung cancer cases at diagnosis: case-control findings.
Hwang SH; Ryu HJ; Kang SJ; Yun EH; Lim MK; Kim HT; Lee JS; Lee DH
Asian Pac J Cancer Prev; 2014 Jan; 14(11):6591-3. PubMed ID: 24377573
[TBL] [Abstract][Full Text] [Related]
34. Epidemiological study of urinary 6beta-hydroxycortisol to cortisol ratios and breast cancer risk.
Zheng W; Jin F; Dunning LA; Shu XO; Dai Q; Wen WQ; Gao YT; Holtzman JL
Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):237-42. PubMed ID: 11303593
[TBL] [Abstract][Full Text] [Related]
35. Comparison of polymorphisms in genes involved in polycyclic aromatic hydrocarbon metabolism with urinary phenanthrene metabolite ratios in smokers.
Hecht SS; Carmella SG; Yoder A; Chen M; Li ZZ; Le C; Dayton R; Jensen J; Hatsukami DK
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1805-11. PubMed ID: 17035385
[TBL] [Abstract][Full Text] [Related]
36. Association between 8-oxo-7,8-dihydroguanine excretion and risk of lung cancer in a prospective study.
Loft S; Svoboda P; Kawai K; Kasai H; Sørensen M; Tjønneland A; Vogel U; Møller P; Overvad K; Raaschou-Nielsen O
Free Radic Biol Med; 2012 Jan; 52(1):167-72. PubMed ID: 22044660
[TBL] [Abstract][Full Text] [Related]
37. Serum mass profile signature as a biomarker of early lung cancer.
Widlak P; Pietrowska M; Polanska J; Marczyk M; Ros-Mazurczyk M; Dziadziuszko R; Jassem J; Rzyman W
Lung Cancer; 2016 Sep; 99():46-52. PubMed ID: 27565913
[TBL] [Abstract][Full Text] [Related]
38. Identification of urine protein biomarkers with the potential for early detection of lung cancer.
Zhang H; Cao J; Li L; Liu Y; Zhao H; Li N; Li B; Zhang A; Huang H; Chen S; Dong M; Yu L; Zhang J; Chen L
Sci Rep; 2015 Jul; 5():11805. PubMed ID: 26133466
[TBL] [Abstract][Full Text] [Related]
39. Urine Proteome Profiling Predicts Lung Cancer from Control Cases and Other Tumors.
Zhang C; Leng W; Sun C; Lu T; Chen Z; Men X; Wang Y; Wang G; Zhen B; Qin J
EBioMedicine; 2018 Apr; 30():120-128. PubMed ID: 29576497
[TBL] [Abstract][Full Text] [Related]
40. Derivation of a bronchial genomic classifier for lung cancer in a prospective study of patients undergoing diagnostic bronchoscopy.
Whitney DH; Elashoff MR; Porta-Smith K; Gower AC; Vachani A; Ferguson JS; Silvestri GA; Brody JS; Lenburg ME; Spira A
BMC Med Genomics; 2015 May; 8():18. PubMed ID: 25944280
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
